# Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF)

> 医疗保健 · CN · 以 CNY 报告

Sponda 的基本面指标，已按通胀调整。

[HTML 版本](https://sponda.capital/zh/SHEZF/fundamentals)

## 年度数据

| 年份 | 营业收入 (M) | 净利润 (M) | FCF (M) | 债务 (M) | 股东权益 (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | ¥ 1.33B | ¥ 187.57M | ¥ 355.60M | ¥ 2.79B | ¥ 12.18B |
| 2025 | ¥ 4.10B | ¥ 217.76M | ¥ 1.21B | ¥ 2.11B | ¥ 12.03B |
| 2024 | ¥ 5.30B | ¥ 649.88M | ¥ 2.01B | ¥ 2.98B | ¥ 12.15B |
| 2023 | ¥ 7.25B | ¥ -712.22M | ¥ -144.69M | ¥ 5.56B | ¥ 11.91B |
| 2022 | ¥ 5.41B | ¥ 654.15M | ¥ -884.40M | ¥ 6.99B | ¥ 12.36B |
| 2021 | ¥ 6.50B | ¥ 245.77M | ¥ 396.25M | ¥ 5.65B | ¥ 11.41B |
| 2020 | ¥ 5.52B | ¥ 1.06B | ¥ -142.51M | ¥ 5.65B | ¥ 11.57B |
| 2019 | ¥ 4.80B | ¥ 1.10B | ¥ -612.21M | ¥ 6.30B | ¥ 7.35B |
| 2018 | ¥ 5.00B | ¥ 640.78M | ¥ 109.93M | ¥ 4.92B | ¥ 6.07B |
| 2017 | ¥ 2.95B | ¥ 145.09M | ¥ -1.17B | ¥ 4.71B | ¥ 7.58B |
| 2016 | ¥ 2.54B | ¥ 446.60M | ¥ -15.15M | ¥ 3.89B | ¥ 7.97B |
| 2015 | ¥ 2.63B | ¥ 665.36M | ¥ 831.85M | ¥ 2.45B | ¥ 8.72B |
| 2014 | ¥ 2.28B | ¥ 394.49M | ¥ 869.00M | ¥ 1.01B | ¥ 8.27B |
| 2013 | ¥ 1.79B | ¥ 375.28M | ¥ 150.18M | ¥ 0 | ¥ 7.99B |
| 2012 | ¥ 2.14B | ¥ 756.91M | ¥ -287.96M | ¥ 73.16M | ¥ 7.96B |
| 2011 | ¥ 3.10B | ¥ 773.20M | ¥ -166.76M | ¥ 0 | ¥ 7.82B |
| 2010 | ¥ 4.98B | ¥ 1.56B | ¥ -46.46M | ¥ 0 | ¥ 7.99B |
| 2009 | ¥ 3.01B | ¥ 1.09B | ¥ -74.25M | ¥ 244.00M | ¥ 1.06B |

此视图中不可用的列：annualPriceMultiples, dividends。它们需要实时市场数据，仅在 HTML 页面上显示。

## 杠杆与流动性

| 指标 | 数值 |
| --- | --- |
| 总债务 / 股东权益 | 0.23 |
| 总负债 / 股东权益 | 0.39 |
| 流动比率 | 2.15 |

## 债务覆盖

| 指标 | 数值 |
| --- | --- |
| 总债务 / 盈利 | 6.01 |
| 总债务 / 自由现金流 | 24.96 |

## 其他视图

- [指标](https://sponda.capital/zh/SHEZF.md)
- [图表](https://sponda.capital/zh/SHEZF/charts.md)
- [对比](https://sponda.capital/zh/SHEZF/compare.md)
- [指标定义](https://sponda.capital/zh/screener.md)

数据截至 2026-08-23。